116 related articles for article (PubMed ID: 8202193)
1. Evaluation of phthalmustine, a new anticancer compound. I. Effect on Dalton's ascitic lymphoma in mice.
Bhattacharya S; Ganguly C; Sanyal U; Das S
Neoplasma; 1994; 41(1):35-8. PubMed ID: 8202193
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
[TBL] [Abstract][Full Text] [Related]
3. [Comparative characteristics of the toxicity and antitumor activity of a number of haloid derivatives of embikhin and Nor HN2].
Demirchoglian IG; Babasian OV; Galstian DA
Zh Eksp Klin Med; 1979; 19(5):46-52. PubMed ID: 525103
[No Abstract] [Full Text] [Related]
4. Inhibitory effect of Abrus abrin-derived peptide fraction against Dalton's lymphoma ascites model.
Bhutia SK; Mallick SK; Maiti S; Maiti TK
Phytomedicine; 2009 Apr; 16(4):377-85. PubMed ID: 18706794
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of toxicity of cypenhymustine, a new anticancer compound, in mice.
Sadhu U; Ghosh M; Bhattacharya S; Dutta S; Das H; Sanyal U
Cancer Lett; 1994 Sep; 85(1):65-72. PubMed ID: 7923104
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Qazi GN; Sanyal U
J Exp Clin Cancer Res; 2003 Sep; 22(3):411-8. PubMed ID: 14582700
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the anticancer property of a new alpha-methylene-gamma-lactone derivative of phthalimide.
Sanyal U; Dutta S; Das H
Neoplasma; 1995; 42(3):129-32. PubMed ID: 7637822
[TBL] [Abstract][Full Text] [Related]
8. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M
Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165
[TBL] [Abstract][Full Text] [Related]
9. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic effectiveness of PTT-119 evaluated in vivo in experimental models].
Bianchi R; Nardelli B; Allegrucci M; Fioretti MC
G Ital Chemioter; 1985; 32(1):1-6. PubMed ID: 3830770
[No Abstract] [Full Text] [Related]
11. Use of subtherapeutical dose of cisplatin and vitamin C against murine Dalton's lymphoma.
Prasad SB; Giri A; Arjun J
Pol J Pharmacol Pharm; 1992; 44(4):383-91. PubMed ID: 1287602
[TBL] [Abstract][Full Text] [Related]
12. Anticancer potential of cleistanthin A isolated from the tropical plant Cleistanthus collinus.
Pradheepkumar CP; Shanmugam G
Oncol Res; 1999; 11(5):225-32. PubMed ID: 10608617
[TBL] [Abstract][Full Text] [Related]
13. [On the growth-inhibiting effect of some new N mustard compounds on Ehrlich ascites carcinoma, Nemeth-Kellner lymphoma (ascites form) and solid sarcoma 180].
Jugstand W; Gutsche W; Wiangke H
Arzneimittelforschung; 1966 May; 16(5):634-7. PubMed ID: 6014431
[No Abstract] [Full Text] [Related]
14. Anticarcinogenic activity of Withania somnifera Dunal against Dalton's ascitic lymphoma.
Christina AJ; Joseph DG; Packialakshmi M; Kothai R; Robert SJ; Chidambaranathan N; Ramasamy M
J Ethnopharmacol; 2004 Aug; 93(2-3):359-61. PubMed ID: 15234777
[TBL] [Abstract][Full Text] [Related]
15. [Antiblastic effect of various chemotherapeutic preparations on the cells of the Ehrlich ascites tumor].
Papoian SA; Kumkumadzhian VA
Vopr Onkol; 1966 Apr; 12(4):56-61. PubMed ID: 6001002
[No Abstract] [Full Text] [Related]
16. Sex dimorphism in antitumor response of chemotherapeutic drug cisplatin in a murine host-bearing a T-cell lymphoma.
Gupta V; Singh SM
Anticancer Drugs; 2008 Jul; 19(6):583-92. PubMed ID: 18525317
[TBL] [Abstract][Full Text] [Related]
17. Preclinical studies of steroid-linked nitrosoureas in murine pancreatic adenocarcinoma PANO2.
Papageorgiou A; Lialiaris T; Stergiou E; Stergiou I; Tsigris C; Kourti A; Geromichalos G; Stravoravdi P; Trafalis D; Athanassiou AE; Pitsas A; Camoutsis Ch
J BUON; 2008; 13(2):235-9. PubMed ID: 18555471
[TBL] [Abstract][Full Text] [Related]
18. Antitumor and proapoptotic effect of Abrus agglutinin derived peptide in Dalton's lymphoma tumor model.
Bhutia SK; Mallick SK; Maiti S; Maiti TK
Chem Biol Interact; 2008 Jul; 174(1):11-8. PubMed ID: 18550041
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of 'cypenhymustine', a new anticancer compound, in murine tumour models.
Sanyal U; Bhattacharya S; Sadhu U; Dutta S; Das H; Ghosh M
Cancer Lett; 1993 Jun; 70(1-2):1-6. PubMed ID: 8330289
[TBL] [Abstract][Full Text] [Related]
20. Antitumour activity of some plants from Meghalaya and Mizoram against murine ascites Dalton's lymphoma.
Rosangkima G; Prasad SB
Indian J Exp Biol; 2004 Oct; 42(10):981-8. PubMed ID: 15511001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
